Top compounds associated with response to CTD-2331H12.8


Feature Type Standardized
Nominal ANOVA
mRNA Methotrexate CTRPv2 pan-cancer AAC -0.12 0.002
mRNA tipifarnib CTRPv2 pan-cancer AAC 0.098 0.002
mRNA Cerulenin CTRPv2 pan-cancer AAC 0.1 0.002
mRNA epigallocatechin-3-monogallate CTRPv2 pan-cancer AAC 0.11 0.003
mRNA AT-406 CTRPv2 pan-cancer AAC 0.14 0.003
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.003
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.004
mRNA CBB-1007 CTRPv2 pan-cancer AAC 0.16 0.004
mRNA BRD-K13999467 CTRPv2 pan-cancer AAC 0.11 0.004
mRNA AZD6244 CTRPv2 pan-cancer AAC -0.1 0.005
Download CSV